Labcorp Launches New Test to Accelerate Path to Diagnosis of Alzheimer's Disease
Test is available through physicians for use with patients being evaluated for possible Alzheimer's disease or other causes of cognitive impairment
Labcorp is the first company to deliver a blood-based Amyloid-Tau-Neurodegeneration (ATN) Profile, which ... Diagnostics, Neurology, Product Launch Labcorp , ATN Profile, Alzheimer's disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news